SCHEMBL4655065

SCHEMBL4655065

[c]1ccc2nc(Oc3ccccc3)ccc2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 6/20 0.45
ALDH1A1 P00352 3/20 0.45
MAP4K4 O95819 1/20 0.41
BCAT2 O15382 1/20 0.39
KMT2A Q03164 5/20 0.37
MEN1 O00255 4/20 0.37
HPGD P15428 3/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
ATM Q13315 2/20 0.37
KDM4E B2RXH2 2/20 0.37
HSD17B10 Q99714 1/20 0.37
MAPT P10636 2/20 0.37
GLA P06280 1/20 0.37
MAPK1 P28482 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
LTA4H P09960 1/20 0.35
TSHR P16473 1/20 0.35
HAO1 Q9UJM8 1/20 0.35
L3MBTL1 Q9Y468 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3317518 0.84 HTT (0.45) HTTALDH1A1MAP4K4KMT2AMEN1
SCHEMBL13583086 0.80 MEN1 (0.34) HTTALDH1A1MAP4K4KMT2AMEN1
SCHEMBL8560759 0.79 HTT (0.43) HTTALDH1A1MAP4K4KMT2AMEN1
SCHEMBL3316531 0.78 ALDH1A1 (0.40) HTTALDH1A1KMT2AMEN1HPGD
SCHEMBL199906 0.78 HTT (0.58) HTTALDH1A1MAP4K4BCAT2KMT2A
SCHEMBL31595897 0.78 HTT (0.58) HTTALDH1A1MAP4K4BCAT2KMT2A
Hydrochloric Acid SCHEMBL27672403 0.77 HTT (0.56) HTTALDH1A1MAP4K4BCAT2KMT2A
SCHEMBL28342438 0.77 HTT (0.56) HTTALDH1A1MAP4K4BCAT2KMT2A
SCHEMBL3312917 0.76 KDM4E (0.33) HTTALDH1A1MAP4K4KDM4ELMNA
SCHEMBL194114 0.75 MTNR1A (0.34) ALDH1A1KMT2AHPGDKDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501801-B1 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF VLA-4 DEPENDENT DISEASES UCB PHARMA SA (BE) 2008-01-23 EP claimed